ETF PRO AIOctober 7, 2026
PPH VanEck Pharmaceutical ETF
Fund tearsheet · data as of the latest session · October 7, 2026
ONE YEAR OF DAILY CLOSES
0.36%expense ratio
$1Bfund assets
+4.8%return, YTD
+15.4%return, 1 year
+$22Mnet flow, 1 month
+$308Mnet flow, 1 year
17.7%realized volatility, 1y
-11.5%worst drawdown, 1y
Top ten holdings
| 1 | LLY ELI LILLY | 20.69% |
| 2 | MRK MERCK & CO | 13.39% |
| 3 | NVO NOVO NORDISK A S | 5.58% |
| 4 | PFE PFIZER | 5.09% |
| 5 | TEVA TEVA PHARMACEUTICAL | 4.80% |
| 6 | MCK MCKESSON | 4.63% |
| 7 | BMY BRISTOL MYERS SQUIBB | 4.83% |
| 8 | COR CENCORA INC | 4.38% |
| 9 | GSK GSK | 4.43% |
| 10 | ABBV ABBVIE | 3.69% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS